Events and Presentations

Guggenheim Healthcare Talks—Genomic Medicines and Rare Disease Day Conference
 Thursday, April 1, 2021
 6:00am PDT
  • Panel on Duchenne Muscular Dystrophy (DMD) - Participants include:
    • Arthur Levin, PhD, Chief Scientific Officer, Avidity Biosciences
    • Michael Binks, MD, Vice President of Clinical Research, Pfizer
    • Louise Rodino-Klapac, PhD, Chief Scientific Officer, Sarepta Therapeutics
    • Carl Morris, PhD, Chief Scientific Officer, Solid Biosciences
    • Sam Wadsworth, Chief Scientific Officer, Ultragenyx Pharmaceutical
Subscribe to Investor Alerts
INVESTOR RESOURCES
* Required Fields